Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers

INTRODUCTION: Cytokine-release syndrome (CRS) in COVID-19 patients can cause multiorgan failure and higher mortality. We used a structured protocol based on clinical, biochemical, and interleukin 6 (IL-6) criteria for the identification of the subset of patients with CRS and analyzed the use of toci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Crit Care Med
Main Authors: Nasa, Prashant, Singh, Aanchal, Upadhyay, Surjya, Bagadia, Sukhant, Polumuru, Srinivasa, Shrivastava, Pavan K, Sankar, Rakesh, Vijayan, Lexy, Soliman, Mohamed A, Ali, Alaeldin, Patidar, Saroj
Formato: Artigo
Idioma:Inglês
Publicado em: Jaypee Brothers Medical Publishers 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7584850/
https://ncbi.nlm.nih.gov/pubmed/33132558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10071-23566
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados